S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway
Authors
Keywords
ESCC, S1PR1, STAT3, Proliferation, Apoptosis
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-22
DOI
10.1186/s13046-019-1369-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Apolipoprotein M promotes proliferation and invasion in non-small cell lung cancers via upregulating S1PR1 and activating the ERK1/2 and PI3K/AKT signaling pathways
- (2018) Yifei Zhu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis
- (2018) Masayuki Nagahashi et al. CANCER RESEARCH
- Corilagin inhibits breast cancer growth via reactive oxygen species-dependent apoptosis and autophagy
- (2018) Yinping Tong et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Targeting S1PR1/STAT3 loop abrogates desmoplasia and chemosensitizes pancreatic cancer to gemcitabine
- (2018) Manendra Babu Lankadasari et al. Theranostics
- Corrigendum: Sphingosine 1-Phosphate: A Novel Target for Lung Disorders
- (2018) Sabira Mohammed et al. Frontiers in Immunology
- Effectiveness of Intensive Endoscopic Screening for Esophageal Cancer in China: A Community-Based Study
- (2018) Mengfei Liu et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Unconventional Ways to Live and Die: Cell Death and Survival in Development, Homeostasis, and Disease
- (2018) Swapna A. Gudipaty et al. Annual Review of Cell and Developmental Biology
- Targeting the sphingosine 1-phosphate axis exerts potent antitumor activity in BRAFi-resistant melanomas
- (2018) David Garandeau et al. MOLECULAR CANCER THERAPEUTICS
- Molecular mechanisms of biogenesis of apoptotic exosome-like vesicles and their roles as damage-associated molecular patterns
- (2018) Soo Jeong Park et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway
- (2018) Shikun Yang et al. Cell Death & Disease
- S1PR1 predicts patient survival and promotes chemotherapy drug resistance in gastric cancer cells through STAT3 constitutive activation
- (2018) Shiyu Song et al. EBioMedicine
- S1PR1 drives a feedforward signalling loop to regulate BATF3 and the transcriptional programme of Hodgkin lymphoma cells
- (2017) K Vrzalikova et al. LEUKEMIA
- Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response
- (2017) Ioannis K. Zervantonakis et al. Nature Communications
- Hypothalamic S1P/S1PR1 axis controls energy homeostasis in Middle-Aged Rodents: the reversal effects of physical exercise
- (2016) Vagner Ramon Silva et al. Aging-US
- Melatonin prevents deregulation of the sphingosine kinase/sphingosine 1-phosphate signaling pathway in a mouse model of diethylnitrosamine-induced hepatocellular carcinoma
- (2016) Diana I. Sánchez et al. JOURNAL OF PINEAL RESEARCH
- FTY720 (Fingolimod) Inhibits HIF1 and HIF2 Signaling, Promotes Vascular Remodeling, and Chemosensitizes in Renal Cell Carcinoma Animal Model
- (2016) C. Gstalder et al. MOLECULAR CANCER THERAPEUTICS
- Genome-wide analysis of the effect of esophageal squamous cell carcinoma on human umbilical vein endothelial cells
- (2016) GUOGUO JIN et al. ONCOLOGY REPORTS
- Targeting transcription factor STAT3 for cancer prevention and therapy
- (2016) Edna Zhi Pei Chai et al. PHARMACOLOGY & THERAPEUTICS
- Interference with distinct steps of sphingolipid synthesis and signaling attenuates proliferation of U87MG glioma cells
- (2015) Eva Bernhart et al. BIOCHEMICAL PHARMACOLOGY
- The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3 in Esophageal Squamous Cell Carcinoma
- (2015) H.-F. Zhang et al. CLINICAL CANCER RESEARCH
- Sphingosine-1-phosphate receptor 1 (S1PR1) expression in non-muscle invasive urothelial carcinoma: Association with poor clinical outcome and potential therapeutic target
- (2015) Heounjeong Go et al. EUROPEAN JOURNAL OF CANCER
- Prognostic Factors and Risk Groups in T1G3 Non–Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients
- (2015) Paolo Gontero et al. EUROPEAN UROLOGY
- IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis
- (2015) Matjaz Rokavec et al. JOURNAL OF CLINICAL INVESTIGATION
- Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
- (2015) Jianhui Chang et al. NATURE MEDICINE
- Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis
- (2015) Gregor Ebert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- STAT3 Mediates Regorafenib-Induced Apoptosis in Hepatocellular Carcinoma
- (2014) W.-T. Tai et al. CLINICAL CANCER RESEARCH
- Dynamin 2–dependent endocytosis is required for sustained S1PR1 signaling
- (2014) Tim Willinger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Individual variation of human S1P1coding sequence leads to heterogeneity in receptor function and drug interactions
- (2014) Hideru Obinata et al. JOURNAL OF LIPID RESEARCH
- In silico simulations of STAT1 and STAT3 inhibitors predict SH2 domain cross-binding specificity
- (2013) Malgorzata Szelag et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A review of the current understanding and clinical utility of miRNAs in esophageal cancer
- (2013) Naomi S. Sakai et al. SEMINARS IN CANCER BIOLOGY
- Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma
- (2013) Sina Haftchenary et al. ACS Medicinal Chemistry Letters
- Sphingosine-1-Phosphate Links Persistent STAT3 Activation, Chronic Intestinal Inflammation, and Development of Colitis-Associated Cancer
- (2012) Jie Liang et al. CANCER CELL
- Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts
- (2011) Vladimir Beljanski et al. CANCER BIOLOGY & THERAPY
- Female Gender and Carcinoma In Situ in the Prostatic Urethra Are Prognostic Factors for Recurrence, Progression, and Disease-Specific Mortality in T1G3 Bladder Cancer Patients Treated With Bacillus Calmette-Guérin
- (2011) Joan Palou et al. EUROPEAN UROLOGY
- Signal transducer and activator of transcription 3 (STAT3): a promising target for anticancer therapy
- (2011) Daniela Masciocchi et al. Future Medicinal Chemistry
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors
- (2010) Heehyoung Lee et al. NATURE MEDICINE
- Mitochondrial STAT3 Supports Ras-Dependent Oncogenic Transformation
- (2009) D. J. Gough et al. SCIENCE
- Targeting STAT3 in cancer: how successful are we?
- (2008) Peibin Yue et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now